ArticleCancers2020

Autocrine Signaling of NRP1 Ligand Galectin-1 Elicits Resistance to BRAF-Targeted Therapy in Melanoma Cells.

Sabrina Rizzolio et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.